Dr. Colleen Le Prell, an associate professor in the department of speech, language, and hearing sciences at the University of Florida (Photo by Jesse Jones/University of Florida)

Researchers from the University of Florida are starting a clinical trial targeting the 30 million Americans that are exposed to noise that may lead to hearing loss. Dr. Colleen Le Prell, an associate professor in the department of speech, language, and hearing sciences at the University of Florida, will lead the first FDA-approved clinical trial testing a drug that may help protect hearing during noise exposure. The drug will be administered to participants to see whether it protects against temporary hearing loss.

Comments are closed.

You can follow any responses to this entry through the RSS 2.0 feed.